EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Factors associated with SARS-CoV-2 testing, diagnosis and COVID-19 disease among individuals prescribed opioid-agonist treatment: a nationwide retrospective cohort study

Megan Glancy, Alan Yeung, Andrew McAuley, Norah Palmateer, Jen Bishop, Bob Taylor, Jaroslaw Lang, Lee Barnsdale, Saket Priyadarshi, Sharon Hutchinson

Clinical Microbiology and Infection · 2024

DOI: 10.1016/j.cmi.2024.06.019 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Microbiology and Infection, 2024. Verfasst von Megan Glancy und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK; Public Health Scotland, Glasgow, UK. Electronic address: Megan.Glancy…. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Hospitalization, Analgesics, Opioid. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Public Health Scotland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Among people receiving opioid-agonist treatment (OAT), the risk of COVID-19 infection and disease may be higher owing to underlying health problems and vulnerable social circumstances. We aimed to determine whether recent OAT, when compared with past exposure, affected the risk of (i) testing for SARS-CoV-2, (ii) testing positive for SARS-CoV-2, and (iii) being hospitalized or dying with COVID-19 disease. METHODS: We included individuals prescribed OAT in Scotland from 2015 to 2020. We performed record linkage to SARS-CoV-2 PCR testing, vaccination, hospitalization, and mortality data, and followed up from March 2020 to December 2021. We used proportional hazards analysis and multivariate logistic regression to estimate associations between recent OAT prescription (in the previous 2 months), compared with past exposure (off treatment for over a year), and COVID-19 outcomes. Models were adjusted for confounders. RESULTS: Among 36 093 individuals prescribed OAT, 19 071 (52.9%) were tested for SARS-CoV-2; 2896 (8.3%) tested positive; and 552 (1.5%) were hospitalized or died with COVID-19. Recent OAT, compared with past exposure, was associated with lower odds of testing positive among those tested (aOR, 0.63; 95% CI, 0.57-0.69). However, among those testing positive, recent OAT was associated with two-fold higher odds of hospitalization or death (aOR, 2.04; 95% CI, 1.60-2.59). DISCUSSION: We found that recent OAT was associated with lower odds of SARS-CoV-2 infection, but with higher odds of disease once diagnosed. Clinical studies are needed to unravel the role of OAT in these associations. An enhanced effort is warranted to increase vaccine coverage among OAT patients to mitigate the severe consequences of COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2HospitalizationAnalgesics, OpioidHumansMaleFemaleRetrospective StudiesMiddle AgedAdultScotlandCOVID-19 TestingAgedYoung AdultRisk FactorsOpiate Substitution Treatment

Stichwörter der Autor:innen

COVID-19Data linkageEpidemiologyOpioid dependenceOpioid-agonist treatmentPeople who inject drugsSARS-CoV-2Vaccine

Substanzen

Analgesics, Opioid

Autor:innen und Institutionen

  • School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK; Public Health Scotland, Glasgow, UK. Electronic address: Megan.Glancy@gcu.ac.uk.
  • School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK; Public Health Scotland, Glasgow, UK.
  • Public Health Scotland, Glasgow, UK.
  • School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK; Glasgow Alcohol and Drug Recovery Services, Glasgow, UK.

Förderung

  • Public Health Scotland

Zitieren

APA

Glancy, M., Yeung, A., McAuley, A., Palmateer, N., Bishop, J., Taylor, B., Lang, J., Barnsdale, L., Priyadarshi, S., & Hutchinson, S. (2024). Factors associated with SARS-CoV-2 testing, diagnosis and COVID-19 disease among individuals prescribed opioid-agonist treatment: a nationwide retrospective cohort study. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2024.06.019

Vancouver

Glancy M, Yeung A, McAuley A, Palmateer N, Bishop J, Taylor B, et al. Factors associated with SARS-CoV-2 testing, diagnosis and COVID-19 disease among individuals prescribed opioid-agonist treatment: a nationwide retrospective cohort study. Clinical Microbiology and Infection. 2024. doi:10.1016/j.cmi.2024.06.019

BibTeX
@article{Glancy2024,
  author = {Glancy, Megan and Yeung, Alan and McAuley, Andrew and Palmateer, Norah and Bishop, Jen and Taylor, Bob and Lang, Jaroslaw and Barnsdale, Lee and Priyadarshi, Saket and Hutchinson, Sharon},
  title = {Factors associated with SARS-CoV-2 testing, diagnosis and COVID-19 disease among individuals prescribed opioid-agonist treatment: a nationwide retrospective cohort study},
  journal = {Clinical Microbiology and Infection},
  year = {2024},
  doi = {10.1016/j.cmi.2024.06.019}
}
Kostenlos starten →